Ansa Biotechnologies wants to usher in a new era of DNA manufacturing

SourceTech Crunch
Date Published09/17/2020
Author NameJonathan Shieber
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Ansa Biotechnologies, Inc.
Type of work Manufacturing
If manufacturing, is the company an OEM? Yes
Reshoring category:Reshoring
Year reshoring announced:2020
Year reshoring implemented or to be implemented:2020
Domestically, the work will be done:In-house
Capital investment ($):7.9
City reshored to:Berkeley
State(s) reshored to:CA
If relevant, work nearshored to:-
Product(s) reshoredsynthetic DNA manufacturing, engineering biology
What domestic positive factors made reshoring more attractive?Lead time/Time to market, vet clients for biosecurity
Find Reshoring Articles